Pulse of the Market: Wednesday’s 10 Top Performers

3. ADMA Biologics Inc. (NASDAQ:ADMA)

ADMA Biologics extended its winning streak for a fourth straight day on Wednesday, adding 10.16 percent to finish at $20.61 apiece in line with the overall market rally, further supported by a bullish outlook and impressive earnings performance last year.

In its latest earnings results, ADMA said it swung to a net income of $112 million in the fourth quarter of 2024 from a $17.6 million net loss in the same period a year earlier. Revenue, on the other hand, spiked by 58 percent to $117 million from $73.9 million year-on-year.

For the full year, ADMA registered a $197.67 million net profit, reversing a $28.2 million net loss in 2023, as revenues jumped by 79.8 percent to $426 million from $258 million.

For this year, ADMA expects revenues to end at $490 million and increase to $605 million in 2026, with adjusted net income targeted at $175 million and $235 million, respectively.